{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "anhedonia",
      "antidepressant treatment",
      "childhood maltreatment",
      "major depression"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [
    {
      "AbstractText": [
        "Les mauvais traitements dans l\u2019enfance sont un puissant marqueur environnemental du risque d\u2019une mauvaise r\u00e9ponse aux m\u00e9dicaments antid\u00e9presseurs (MAD). Toutefois, les mauvais traitements dans l\u2019enfance sont une construction h\u00e9t\u00e9rog\u00e8ne qui inclut des expositions distinctes ayant des corr\u00e9lats neurobiologiques et psychologiques distincts. Le but de la pr\u00e9sente \u00e9tude est d\u2019examiner les associations diff\u00e9rentielles de mauvais traitements \u00e9motionnels, physiques et sexuels avec les r\u00e9sultats des MAD et d\u2019examiner le r\u00f4le unique de l\u2019anh\u00e9donie qui entra\u00eene une mauvaise r\u00e9ponse chez les patients qui ont des ant\u00e9c\u00e9dents sp\u00e9cifiques de mauvais traitements.",
        "Dans un essai clinique multicentrique de la d\u00e9pression majeure, 164 personnes ont \u00e9t\u00e9 \u00e9valu\u00e9es relativement aux mauvais traitements \u00e9motionnels, physiques et sexuels dans l\u2019enfance et ont r\u00e9pondu \u00e0 une entrevue contextuelle avec des notations ind\u00e9pendantes, standardis\u00e9es. Toutes les personnes ont re\u00e7u 8 semaines d\u2019escitalopram, et les non-r\u00e9pondants ont re\u00e7u subs\u00e9quemment \u00e9galement une augmentation d\u2019aripiprazole, et les r\u00e9sultats ont \u00e9t\u00e9 mesur\u00e9s avec des \u00e9chelles d\u2019\u00e9valuation de la d\u00e9pression et une \u00e9chelle d\u2019anh\u00e9donie.",
        "Les mauvais traitements \u00e9motionnels plus graves perp\u00e9tr\u00e9s par la m\u00e8re \u00e9taient un pr\u00e9dicteur significatif et direct de probabilit\u00e9s plus faibles d\u2019une r\u00e9mission \u00e0 16 semaines (RC\u2009=\u20091,68, <i>P</i>\u2009=\u20090,02). En revanche, les relations des mauvais traitements \u00e9motionnels et physiques perp\u00e9tr\u00e9s par le p\u00e8re \u00e0 la r\u00e9mission de 16 semaines \u00e9taient indirectes, conditionn\u00e9es par la plus grande gravit\u00e9 de l\u2019anh\u00e9donie \u00e0 8 semaines.",
        "Nous identifions les mauvais traitements \u00e9motionnels comme \u00e9tant une exposition pr\u00e9coce sp\u00e9cifique qui place les patients \u00e0 risque accru de non-r\u00e9mission par suite d\u2019un traitement pharmacologique. En outre, nous sugg\u00e9rons que l\u2019anh\u00e9donie est un domaine de sympt\u00f4mes principal entra\u00eenant la non-r\u00e9mission chez les patients ayant des ant\u00e9c\u00e9dents particuliers de mauvais traitements."
      ]
    }
  ],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "36785892",
  "DateCompleted": {
    "Year": "2023",
    "Month": "08",
    "Day": "17"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "08",
    "Day": "17"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2023",
        "Month": "02",
        "Day": "13"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1177/07067437231156255"
    ],
    "Journal": {
      "ISSN": "1497-0015",
      "JournalIssue": {
        "Volume": "68",
        "Issue": "8",
        "PubDate": {
          "Year": "2023",
          "Month": "Aug"
        }
      },
      "Title": "Canadian journal of psychiatry. Revue canadienne de psychiatrie",
      "ISOAbbreviation": "Can J Psychiatry"
    },
    "ArticleTitle": "The Differential Relation of Emotional, Physical, and Sexual Abuse Histories to Antidepressant Treatment Remission and Persistence of Anhedonia in Major Depression: A CAN-BIND-1 Report.",
    "Pagination": {
      "StartPage": "586",
      "EndPage": "595",
      "MedlinePgn": "586-595"
    },
    "Abstract": {
      "AbstractText": [
        "Childhood maltreatment is a potent enviromarker of risk for poor response to antidepressant medication (ADM). However, childhood maltreatment is a heterogeneous construct that includes distinct exposures that have distinct neurobiological and psychological correlates. The purpose of the current study is to examine the differential associations of emotional, physical, and sexual maltreatment to ADM outcome and to examine the unique role of anhedonia in driving poor response in patients with specific maltreatment histories.",
        "In a multicentre clinical trial of major depression, 164 individuals were assessed for childhood emotional, physical, and sexual maltreatment with a contextual interview with independent, standardized ratings. All individuals received 8 weeks of escitalopram, with nonresponders subsequently also receiving augmentation with aripiprazole, with outcomes measured with depression rating scales and an anhedonia scale.",
        "Greater severity of emotional maltreatment perpetrated by the mother was a significant and direct predictor of lower odds of week 16 remission (odds ratio [OR]\u2009=\u20091.68, <i>P</i>\u2009=\u20090.02). In contrast, the relations of paternal-perpetrated emotional maltreatment and physical maltreatment to week 16 remission were indirect, mediated through greater severity of anhedonia at week 8.",
        "We identify emotional maltreatment as a specific early exposure that places patients at the greatest risk for nonremission following pharmacological treatment. Further, we suggest that anhedonia is a key symptom domain driving nonremission in patients with particular maltreatment histories."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [
          "0000-0002-0319-8994"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Psychology, Queen's University, Kingston, ON, Canada."
          }
        ],
        "LastName": "Harkness",
        "ForeName": "Kate L",
        "Initials": "KL"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada."
          }
        ],
        "LastName": "Chakrabarty",
        "ForeName": "Trisha",
        "Initials": "T"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Centre for Depression and Suicide Studies, St. Michael's Hospital, Toronto ON, Canada."
          },
          {
            "Identifier": [],
            "Affiliation": "Department of Psychiatry, University of Toronto, Toronto, ON, Canada."
          }
        ],
        "LastName": "Rizvi",
        "ForeName": "Sakina J",
        "Initials": "SJ"
      },
      {
        "Identifier": [
          "0000-0002-4974-4815"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Psychiatry, Dalhousie University, Halifax, NS, Canada."
          }
        ],
        "LastName": "Mazurka",
        "ForeName": "Raegan",
        "Initials": "R"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Centre for Addiction and Mental Health, University of Toronto, Toronto, ON, Canada."
          }
        ],
        "LastName": "Quilty",
        "ForeName": "Lena",
        "Initials": "L"
      },
      {
        "Identifier": [
          "0000-0002-2998-0546"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Psychiatry, Dalhousie University, Halifax, NS, Canada."
          }
        ],
        "LastName": "Uher",
        "ForeName": "Rudolf",
        "Initials": "R"
      },
      {
        "Identifier": [
          "0000-0001-6884-171X"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Psychiatry, Queen's University, and Providence Care, Kingston, ON, Canada."
          }
        ],
        "LastName": "Milev",
        "ForeName": "Roumen V",
        "Initials": "RV"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, ON, Canada."
          },
          {
            "Identifier": [],
            "Affiliation": "Mood Disorders Program, St. Joseph's Healthcare Hamilton, Hamilton, ON, Canada."
          }
        ],
        "LastName": "Frey",
        "ForeName": "Benicio N",
        "Initials": "BN"
      },
      {
        "Identifier": [
          "0000-0003-4817-3042"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Psychiatry, University of Michigan, Ann Arbor, MI, USA."
          }
        ],
        "LastName": "Parikh",
        "ForeName": "Sagar V",
        "Initials": "SV"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, ON, Canada."
          }
        ],
        "LastName": "Foster",
        "ForeName": "Jane A",
        "Initials": "JA"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Centre for Depression and Suicide Studies, St. Michael's Hospital, Toronto ON, Canada."
          },
          {
            "Identifier": [],
            "Affiliation": "Department of Psychiatry, University of Toronto, Toronto, ON, Canada."
          }
        ],
        "LastName": "Rotzinger",
        "ForeName": "Susan",
        "Initials": "S"
      },
      {
        "Identifier": [
          "0000-0001-5339-7185"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Centre for Depression and Suicide Studies, St. Michael's Hospital, Toronto ON, Canada."
          },
          {
            "Identifier": [],
            "Affiliation": "Department of Psychiatry, University of Toronto, Toronto, ON, Canada."
          }
        ],
        "LastName": "Kennedy",
        "ForeName": "Sidney H",
        "Initials": "SH"
      },
      {
        "Identifier": [
          "0000-0001-7142-4669"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada."
          }
        ],
        "LastName": "Lam",
        "ForeName": "Raymond W",
        "Initials": "RW"
      }
    ],
    "PublicationTypeList": [
      "Clinical Trial",
      "Journal Article",
      "Multicenter Study",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Can J Psychiatry",
    "NlmUniqueID": "7904187",
    "ISSNLinking": "0706-7437"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antidepressive Agents"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Child"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Anhedonia"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Antidepressive Agents"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Child Abuse"
    },
    {
      "QualifierName": [
        "psychology"
      ],
      "DescriptorName": "Depression"
    },
    {
      "QualifierName": [
        "drug therapy",
        "psychology"
      ],
      "DescriptorName": "Depressive Disorder, Major"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Sex Offenses"
    }
  ],
  "CoiStatement": "The authors declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: KH, TC, RM, LQ, RU, BNF, SP, and JAF disclose no relevant conflict of interest. RVM has received consulting and speaking honoraria from AbbVie, Allergan, Eisai, Janssen, KYE, Lallemand, Lundbeck, Otsuka, and Sunovion, and research grants from CAN-BIND, CIHR, Janssen, Lallemand, Lundbeck, Nubiyota, OBI and OMHF. SVP reports receiving research funding from Aifred, Janssen, Sage, Merck, Ontario Brain Institute, and CIHR, and also honoraria from Aifred, Janssen, Myriad, Milken Institute, Neonmind, and Sage. SR holds a patent \u201cTeneurin C-Terminal Associated Peptides (TCAP) and methods and uses thereof. Inventors: David Lovejoy, R.B. Chewpoy, Dalia Barsyte, Susan Rotzinger.\u201d SHK has received research funding or honoraria from the following sources: Abbott, Alkermes, Allergan Abbvie, Brain Canada, Canadian Institutes for Health Research, Janssen, Lundbeck, Lundbeck Institute, Ontario Brain Institute, Ontario Research Fund, Otsuka, Pfizer, Servier, Sunovion and Xian-Janssen and holds stock in Field Trip Health. SJR has received research funding/consultancy fees from the following sources: Allergan, Janssen, Neurocrine, and Pfizer. RWL has received honoraria for ad hoc speaking or advising/consulting, or received research funds, from Asia-Pacific Economic Cooperation, BC Leading Edge Foundation, Canadian Institutes of Health Research, Canadian Network for Mood and Anxiety Treatments, Healthy Minds Canada, Janssen, Lundbeck, Lundbeck Institute, Michael Smith Foundation for Health Research, MITACS, Myriad Neuroscience, Ontario Brain Institute, Otsuka, Pfizer, Sanofi, Unity Health, and VGH-UBCH Foundation."
}